skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy

Journal Article · · Arch. Dermatol.; (United States)

A distinctive cutaneous eruption occurred in two patients with central nervous system tumors who were treated with broxuridine (bromodeoxyuridine) and radiotherapy. Findings included the initial appearance of papular lesions within skin directly overlying acral superficial veins and the later development of a more generalized eruption eventuating into exfoliative erythroderma.

Research Organization:
National Cancer Institute, Bethesda, MD
OSTI ID:
5730834
Journal Information:
Arch. Dermatol.; (United States), Vol. 2
Country of Publication:
United States
Language:
English